Ames Gross of Pacific Bridge Medical provides an overview ... In 2012, Watson Pharmaceuticals inherited a Malaysian facility after it acquired Ascent Pharmahealth. Novartis – which currently ...
DelveInsight’s Refractory Multiple Myeloma pipeline report depicts a robust space with 75+ active players working to develop ...
Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial officer, will ...
Adam Brufsky, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine; Megan Kruse, MD, breast medical oncologist at Cleveland Clinic; and Ruta Rao, MD, professor of medicine ...
The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...
The major players in the market are Hisamitsu Pharmaceuticals, Bayer AG, Novartis AG, Galderma Holding SA ... VMI provides a holistic overview and global competitive landscape with respect to Region, ...
Buccal Drug Delivery System market Size, Share, Revenue, Trends, and Drivers For 2024-2033. Buccal Drug Delivery System Market Size, Share, Revenue, Trends ...
This Overview forms part of a wider collaboration ... In partnership with GSK, WBCSD is convening leading pharmaceutical companies including AstraZeneca, Bayer, Novartis, Novo Nordisk, Reckitt and ...
Read updates from clinical trials and scientific research on Huntington’s disease from Day 1 of the 2024 Huntington Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback